Tagged with M

Genzyme Australia What impact will the recent PBS reforms have on Genzyme’s operations in Australia? Genzyme is different in terms of its focus on rare & unmet medical needs, so most of the company’s products, given they are targeted therapies, are not reimbursed through the PBS, but through other government funding mechanisms.…

Medicines Australia To begin, would you please introduce Medicines Australia to Pharmaceutical Executive readers? Medicines Australia is the national industry association for innovative pharmaceutical companies. . Just about every company engaged in the research and discovery of new medicines in Australia is a member of the association, so we have the capacity…

Laboratorios Richmond What have been the recent major milestones for Richmond? One of the milestones for Laboratorios Richmond was to have developed the first branded oncological generic in the world. For Laboratorios Richmond to be developing combinations of different molecules from different originator laboratories is very important as well, as it provides…

CETIFARMA The Mexican government has been fairly pro-active about promoting good practice such as the new drug registration process that helped eliminate drugs from the Mexican market that didn’t fulfill regulatory therapeutic efficiency. In this context, what is left to do for CETIFARMA? In my opinion when the authorities take a…

Amega Biotech What was the vision behind the creation of the umbrella organisation Amega Biotech in 2005? What led you to consider setting up an organisation with this structure, and offering these services in particular? When we started Amega, the idea was to exploit this argentine know-how that had not been touched…

Thai Pharmaceutical Manufacturers Association TPMA is the main association bringing together the local manufacturers in Thailand. What do you consider to have been the main milestones and achievements since your inception? We haven’t reached any milestones yet. Our first milestone will be to open and free the pharmaceutical market in Thailand by breaking the…

PREMA Thailand PReMa was established in 2004 after a period of transformation to represent the growing role of its members, research-based companies. To begin with, could you explain us the main milestones and achievements of the organization? PReMA has been present in Thailand for 42 years. The association only changed and took…

Temis Lostaló Temis Lostaló was founded in 1968 by your father, Dr. Silvio Macchiavello. What have been the biggest challenges and opportunities of being a family owned company, and how have they affected the growth and development of the business? Lucila Macchiavello (LM): It’s fair to say that most family owned companies…

UNC-HEMODERIVADOS UNC HEMODERIVADOS tiene una estructura muy especial y única con su asociación con la Universidad de Córdoba. ¿Cual fue la visión cuando se creó la empresa? El Laboratorio UNC Hemoderivados es una dependencia de la Universidad Nacional de Córdoba, pero con características de autogestión. Durante muchos años costo definir el…

Massone What has been the history of Massone in Argentina and how has it changed since you took over the company? Since the creation of the company by my grandfather I am glad to say we have been very successful. My grandfather came to Argentina from a small town near Genoa…

Astellas Pharma Ltd. South Africa The South African affiliate was established in June 2003. Could you come back on the main milestones in the company’s development from 2003 onwards? Yamanouchi as an entity was an agency in South Africa under Pharmaplan from 1996. In 1997 I joined Pharmaplan as the Managing Director and ran the…

HLB Pharma Group Your entry into the Argentinean pharmaceutical market in 2004 was very unconventional, with your ‘holistic solution’ that had not been seen before in Argentina. Why was the time right in 2004 to start HLB Pharma? Hernán López Bernabó: We saw a special moment in Argentina to start a new company…